The Effect of Game-based Education on Adherence to Treatment and Anxiety Level in Type 2 Diabetics Started on Insulin Therapy
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 72
- Locations
- 1
- Primary Endpoint
- Treatment Compliance Levels
Study Overview
Brief Summary
The goal of this clinical trial is to learn if an education program can help lower anxiety and improve treatment follow-up in adults with type 2 diabetes. The main questions it aims to answer are:
Does attending the education program lower anxiety levels?
Does it help people better follow their diabetes treatment plan?
Researchers will compare two groups:
Education group: Participants who attend the program.
Control group: Participants who do not attend the program.
Participants will:
Be randomly assigned to either the education group or the control group.
Attend four weekly sessions, each lasting two hours, over one month (education group only).
Complete surveys before and after the program, including the Beck Anxiety Scale (to measure anxiety) and the Patient Compliance Scale for Type 2 Diabetes Mellitus Treatment (to measure treatment follow-up).
Detailed Description
Study Type: This is a clinical trial that tests a diabetes education program. Number of Participants: A total of 72 people participated in the study
Group Assignment: Participants were randomly assigned to one of two groups:
Game-Based Education Group Traditional Education Group Study Model: Both groups were given diabetes education simultaneously, but through different methods Blinding: This was an open-label study in which both the researchers and the participants were aware of the type of education they received
Main Goal: To test whether a game-based education program can:
Improve how well people follow their diabetes treatment plan Lower anxiety levels in people recently starting insulin therapy Groups and Interventions
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •nclusion Criteria:
- •Age at diagnosis of diabetes is at least 1 year.
- •The maximum duration of insulin treatment initiation is 3 months.
- •Not having any mental problems.
- •Between the ages of 40 and 65 years.
- •Volunteering to participate in the study.
Exclusion Criteria
- •Age at diagnosis of diabetes is recent or less than 1 year.
- •Being on insulin therapy for more than three months.
- •Mental or psychological comorbidity.
- •Not within the target age range, under 40 years or over 65 years.
- •Refusing to participate in the research.
- •Not attending one or more of the four training sessions during the research process.
Arms & Interventions
Game-Based Education
Arm Description:
Participants in this group will receive diabetes education using the "Let's Learn Diabetes" board game. The program consists of four weekly sessions, each lasting two hours, conducted over one month. The sessions aim to improve diabetes knowledge, reduce anxiety, and increase adherence to insulin therapy.
Intervention: "Let's Learn Diabetes" Game-Based Education (Behavioral)
Traditional Diabetes Education
Participants in the control group will receive standard diabetes education through traditional lecture-based presentations. The education schedule matches the experimental group with four weekly sessions, each lasting two hours, over one month.
Intervention: Traditional Diabetes Education (Behavioral)
Outcomes
Primary Outcomes
Treatment Compliance Levels
Time Frame: Pre-intervention and Post-intervention (After 1 Month of Training)
For Treatment Compliance: The level of compliance among individuals undergoing diabetes-to-diabetes treatment was determined using the Patient Compliance Scale for Type 2 Diabetes Treatment, a 30-item, five-point Likert-type scale. A low total score indicates high patient compliance. For Anxiety: "Anxiety levels of individuals with diabetes were determined using the Beck Anxiety Scale (BAS), a 21-item, four-point Likert-type self-report scale. Higher scores indicate more severe anxiety.
Secondary Outcomes
No secondary outcomes reported
Investigators
gönül düzgün
assistant profesor
Izmir Tinaztepe University